Yuchen Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuchen Cao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Jie Dong
3 shared publications- Lei Xin
Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China
3 shared publications - Ruiping Zhang
The Radiology Department of Shanxi Provincial People’s Hospital, Fifth Hospital of Shanxi Medical University, Taiyuan, China
3 shared publications - Jian Meng
Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University
2 shared publications Shilei Ren
2 shared publications- Xiao-Dong Zhang
Tianjin University
2 shared publications
Latest Publications
- 20 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (21) , 30624-30626
Correction to “Multifunctional Hydrogels Loaded with Mn Single-Atom Nanozymes: Advancing Endometrial Repair”
- 20 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (21) , 30624-30626
Correction to “Multifunctional Hydrogels Loaded with Mn Single-Atom Nanozymes: Advancing Endometrial Repair”
- 24 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Multifunctional Hydrogels Loaded with Mn Single-Atom Nanozymes: Advancing Endometrial Repair
Irregular endometrial damage often evolves into chronic conditions, such as endometrial thinning, functional tissue fibrosis, and intrauterine adhesions. These conditions pose significant challenges to female reproductive health. Addressing this, we developed a dynamic double-cross-linked hydrogel for the repair of fragile and dynamic endometrial tissue. This hydrogel integrates natural bioactive components (chitosan, protocatechuic aldehyde, and Fe(III)) and serves as a scaffold for Mn single-atom nanozymes (Mn SAN). Through dynamic covalent and hydrogen bonding, the hydrogel exhibits exceptional adhesion, injectability, degradability, and self-healing capabilities. The embedded Mn SAN, leveraging their unique metal active center, deliver superior catalytic activity and selectivity. When introduced into endometrial lesions in mice, this bioactive hydrogel exerts a synergistic effect that not only significantly boosts cell proliferation but also effectively modulates hormone levels. As a result, it facilitates remarkable tissue repair within a mere two-week period. Importantly, this therapeutic approach is both hormone- and cell-free, representing a noninvasive intervention. This innovative design thus paves the way for a groundbreaking strategy in the engineering of advanced materials specifically tailored for endometrial regeneration.
- 24 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Multifunctional Hydrogels Loaded with Mn Single-Atom Nanozymes: Advancing Endometrial Repair
Irregular endometrial damage often evolves into chronic conditions, such as endometrial thinning, functional tissue fibrosis, and intrauterine adhesions. These conditions pose significant challenges to female reproductive health. Addressing this, we developed a dynamic double-cross-linked hydrogel for the repair of fragile and dynamic endometrial tissue. This hydrogel integrates natural bioactive components (chitosan, protocatechuic aldehyde, and Fe(III)) and serves as a scaffold for Mn single-atom nanozymes (Mn SAN). Through dynamic covalent and hydrogen bonding, the hydrogel exhibits exceptional adhesion, injectability, degradability, and self-healing capabilities. The embedded Mn SAN, leveraging their unique metal active center, deliver superior catalytic activity and selectivity. When introduced into endometrial lesions in mice, this bioactive hydrogel exerts a synergistic effect that not only significantly boosts cell proliferation but also effectively modulates hormone levels. As a result, it facilitates remarkable tissue repair within a mere two-week period. Importantly, this therapeutic approach is both hormone- and cell-free, representing a noninvasive intervention. This innovative design thus paves the way for a groundbreaking strategy in the engineering of advanced materials specifically tailored for endometrial regeneration.
- 17 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (39) , 51970-51980
Development of a Controllable Intelligent Drug Delivery System for Efficient Treatment of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a complex inflammatory disease of the joints, which is often accompanied by degeneration of articular cartilage and bone erosion, seriously affecting the quality of life and psychological state of patients. RA is difficult to be cured completely, and currently the main purpose of relief is through the use of anti-inflammatory and antirheumatic drugs, hormones, and biological agents. Tofacitib is a new type of small molecule inhibitor, which has a good effect in the treatment of RA. The current direct drug delivery method has serious side effects caused by the systemic distribution of the drug, so there is a need to develop an intelligent drug delivery system to realize precise treatment. In this work, tofacitib, gallic acid, targeted molecule folic acid, and Fe(III) were selected to assemble a novel type of artificial controllable nanodrug GF-TF. The self-photoacoustic/magnetic resonance imaging (self-PA/MRI) monitored the enrichment of GF-TF in the lesion in real-time, and artificially regulated the addition of deferoxamine (DFO) at the optimal enrichment. DFO strongly chelates Fe(III) in GF-TF and causes its structure to disintegrate gradually, and the self-PA/MRI signal of GF-TF became weaker while tofacitib began to be released, thus realizing the precise and artificially controlled release of the drug under the guidance of imaging. This nanodrug not only achieves efficient aggregation of drugs in inflamed joints, but also achieves real-time monitoring and precise control of drug release through self-PA/MRI, providing a new strategy for the precise treatment of RA.
- 17 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (39) , 51970-51980
Development of a Controllable Intelligent Drug Delivery System for Efficient Treatment of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a complex inflammatory disease of the joints, which is often accompanied by degeneration of articular cartilage and bone erosion, seriously affecting the quality of life and psychological state of patients. RA is difficult to be cured completely, and currently the main purpose of relief is through the use of anti-inflammatory and antirheumatic drugs, hormones, and biological agents. Tofacitib is a new type of small molecule inhibitor, which has a good effect in the treatment of RA. The current direct drug delivery method has serious side effects caused by the systemic distribution of the drug, so there is a need to develop an intelligent drug delivery system to realize precise treatment. In this work, tofacitib, gallic acid, targeted molecule folic acid, and Fe(III) were selected to assemble a novel type of artificial controllable nanodrug GF-TF. The self-photoacoustic/magnetic resonance imaging (self-PA/MRI) monitored the enrichment of GF-TF in the lesion in real-time, and artificially regulated the addition of deferoxamine (DFO) at the optimal enrichment. DFO strongly chelates Fe(III) in GF-TF and causes its structure to disintegrate gradually, and the self-PA/MRI signal of GF-TF became weaker while tofacitib began to be released, thus realizing the precise and artificially controlled release of the drug under the guidance of imaging. This nanodrug not only achieves efficient aggregation of drugs in inflamed joints, but also achieves real-time monitoring and precise control of drug release through self-PA/MRI, providing a new strategy for the precise treatment of RA.
- 3 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (37) , 48880-48894
Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies
Myocardial infarction (MI) is a serious cardiovascular disease with high morbidity and mortality rates, posing a significant threat to patient's health and quality of life. Following a MI, the damaged myocardial tissue is typically not fully repaired, leading to permanent impairment of myocardial function. While traditional treatments can alleviate symptoms and reduce pain, their ability to repair damaged heart muscle tissue is limited. Functionalized hydrogels, a broad category of materials with diverse functionalities, can enhance the properties of hydrogels to cater to the needs of tissue engineering, drug delivery, medical dressings, and other applications. Recently, functionalized hydrogels have emerged as a promising new therapeutic approach for the treatment of MI. Functionalized hydrogels possess outstanding biocompatibility, customizable mechanical properties, and drug-release capabilities. These properties enable them to offer scaffold support, drug release, and tissue regeneration promotion, making them a promising approach for treating MI. This paper aims to evaluate the advancements and delivery methods of functionalized hydrogels for treating MI, while also discussing their potential and the challenges they may pose for future clinical use.
- 3 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (37) , 48880-48894
Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies
Myocardial infarction (MI) is a serious cardiovascular disease with high morbidity and mortality rates, posing a significant threat to patient's health and quality of life. Following a MI, the damaged myocardial tissue is typically not fully repaired, leading to permanent impairment of myocardial function. While traditional treatments can alleviate symptoms and reduce pain, their ability to repair damaged heart muscle tissue is limited. Functionalized hydrogels, a broad category of materials with diverse functionalities, can enhance the properties of hydrogels to cater to the needs of tissue engineering, drug delivery, medical dressings, and other applications. Recently, functionalized hydrogels have emerged as a promising new therapeutic approach for the treatment of MI. Functionalized hydrogels possess outstanding biocompatibility, customizable mechanical properties, and drug-release capabilities. These properties enable them to offer scaffold support, drug release, and tissue regeneration promotion, making them a promising approach for treating MI. This paper aims to evaluate the advancements and delivery methods of functionalized hydrogels for treating MI, while also discussing their potential and the challenges they may pose for future clinical use.